1. Home
  2. DLPN vs SNTI Comparison

DLPN vs SNTI Comparison

Compare DLPN & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.61

Market Cap

20.6M

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.91

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
SNTI
Founded
1996
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.6M
24.5M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
DLPN
SNTI
Price
$1.61
$0.91
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$9.00
AVG Volume (30 Days)
11.9K
100.3K
Earning Date
03-25-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
27.81
N/A
EPS
N/A
N/A
Revenue
$51,684,984.00
N/A
Revenue This Year
$10.62
N/A
Revenue Next Year
$13.78
$150.00
P/E Ratio
N/A
N/A
Revenue Growth
19.85
N/A
52 Week Low
$0.75
$0.80
52 Week High
$1.88
$5.10

Technical Indicators

Market Signals
Indicator
DLPN
SNTI
Relative Strength Index (RSI) 50.28 43.49
Support Level $1.51 $0.80
Resistance Level $1.71 $1.02
Average True Range (ATR) 0.06 0.05
MACD -0.00 -0.01
Stochastic Oscillator 44.90 23.71

Price Performance

Historical Comparison
DLPN
SNTI

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: